Obesity management interventions delivered in primary care for patients with osteoarthritis: a review of clinical effectiveness
CADTH
            Record ID 32015000219
            English
                                                            
                Authors' recommendations:
                Dietary weight loss interventions, either alone or in combination with exercise produced greater reductions in the peak knee compressive force and plasma levels of interleukin-6 (IL-6) in knee OA patients compared with exercise-induced weight loss. Significantly greater reduction in pain and improvements in functions were reported in patients who received diet plus exercise interventions compared with either dietonly or exerciseonly interventions. Regardless of group assignment, participants who lost 10% or more of baseline body weight had greater reductions in knee compressive force, systemic IL-6 concentrations, and pain, as well as gained greater improvement in function than those who lost less of their baseline weight. However, participants who lost the most weight also experienced greater loss of bone mass density at the femoral neck and hip, but not the spine, without a significant change of their baseline clinical classification with regards to osteoporosis or osteopenia. Findings from a cohort study suggest that patients with hip osteoarthritis could achieve weight loss associated with significant improvement in their physical function, mobility, and pain scores.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2014
            
                                    
                URL for published report:
                http://www.cadth.ca/media/pdf/htis/nov-2014/RC0564-003%20Obesity%20Interventions%20%20and%20%20Osteoarthritis%20Final.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                Canada
            
                                                
                        MeSH Terms
            - Humans
- Osteoarthritis
- Primary Health Care
- Obesity
Contact
                        
                Organisation Name:
                Canadian Agency for Drugs and Technologies in Health
            
            
                        
                Contact Address:
                600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
            
                                    
                Contact Name:
                requests@cadth.ca
            
                                    
                Contact Email:
                requests@cadth.ca
            
                                    
                Copyright:
                Canadian Agency for Drugs and Technologies in Health (CADTH)
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.